Latest Articles

Publication Date
First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat - The Manila Times

First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat The Manila Times

Published: March 11, 2026, 2:39 p.m.
First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat - beQuoted

First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat beQuoted

Published: March 11, 2026, 2:01 p.m.
First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat - Cision

First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat Cision

Published: March 11, 2026, 1 p.m.
Transforming endometriosis diagnoses - Scitech

Transforming endometriosis diagnoses Scitech

Published: March 11, 2026, 1:01 a.m.
PhD grad from the U of A is transforming women's health - KVOA

PhD grad from the U of A is transforming women's health KVOA

Published: March 11, 2026, 12:55 a.m.
Simple test could transform time to endometriosis diagnosis - Medical Xpress

Simple test could transform time to endometriosis diagnosis Medical Xpress

Published: March 10, 2026, 7:20 p.m.
Stop Normalising Severe Period Pain: Expert Shares Warning Signs Women Must Not Ignore - NDTV

Stop Normalising Severe Period Pain: Expert Shares Warning Signs Women Must Not Ignore NDTV

Published: March 10, 2026, 3:07 p.m.
Endometriosis breakthrough: Simple five-minute test could transform treatment of agonising condition that affects 190million women worldwide - Daily Mail

Endometriosis breakthrough: Simple five-minute test could transform treatment of agonising condition that affects 190million women worldwide Daily Mail

Published: March 10, 2026, 12:29 p.m.
Endometriosis breakthrough: Simple five-minute test could transform treatment of agonising condition that affects 190million women worldwide - Daily Mail Online

Endometriosis breakthrough: Simple five-minute test could transform treatment of agonising condition that affects 190million women worldwide Daily Mail Online

Published: March 10, 2026, 12:29 p.m.
Absci Highlights AI Antibody Platform, ABS-201 Hair-Loss Trial Milestones at Leerink Conference - MarketBeat

Absci Highlights AI Antibody Platform, ABS-201 Hair-Loss Trial Milestones at Leerink Conference MarketBeat

Published: March 9, 2026, 10:40 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!